Zynteglo Is Cost Effective At $2.1M, ICER Proposes; Validation For Bluebird’s Pivot To US?

 
• By Cathy Kelly
  
Money
ICER says the Zynteglo price could be cost effective • Source: Alamy

More from Drug Pricing

More from Scrip